The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril
Abstract
Arthritis and hypertension are frequent comorbidities in the elderly hypertensive population. Nonsteroidal anti-inflammatory drugs are often used to relieve pain in arthritic patients but a side effect is sodium retention and consequent elevation of blood pressure (BP). The effect of dihydropyridine calcium blocking drugs is relatively independent of sodium intake, whereas the angiotensin-converting enzyme (ACE) inhibitors' effects can be blunted by a high-sodium diet. This study compared the effects of indomethacin with placebo in elderly patients with essential hypertension who had been controlled with amlodipine or enalapril. Indomethacin 50 mg twice daily or placebo was administered for 3 weeks in a double-blind crossover study to patients controlled with amlodipine or enalapril. The response was assessed by ambulatory BP measurement. Indomethacin raised BP and lowered pulse rates in patients taking enalapril but had little effect in patients receiving amlodipine. The difference caused by indomethacin between the two groups was 10.1/4.9 mm Hg increase in BP and a 5.6 beats/min fall in pulse in people taking enalapril. Addition of indomethacin to patients taking either drug caused a rise in weight and a fall in plasma renin. It is postulated that the effect is due to inhibition of prostaglandin synthesis, which causes sodium retention. In patients taking amlodipine, the fall in plasma renin ameliorates the effect of sodium retention on BP. In patients taking enalapril, plasma renin falls but this is not translated into an effect because of the blockage of converting enzyme. Thus, the full effect of sodium retention on BP is expressed. In patients treated with indomethacin, fewer patients may respond to ACE inhibitors. However, the major problem is the patient who intermittently takes indomethacin or other nonsteroidal anti-inflammatory drugs, which, if a person is treated by an ACE inhibitor causes BP to go out of control. In such patients amlodipine would appear to be a preferred choice to enalapril.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The SBP increase with NSAIDs in ACE inhibitor users ranged from 5 to 10 mm Hg.196–199”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [197]
Citations
Cites
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.
Watkins, J. B., Abbott, E., Hensby, C. N., Webster, J., & Dollery, C. T. (1980) · BMJ · doi:10.1136/bmj.281.6242.702 · Cited by 181
Chalmers, J. P., West, M., Wing, L. M. H., Bune, A. J. C., & Graham, J. R. (1984) · Clinical and Experimental Hypertension · doi:10.3109/10641968409039582 · Cited by 88
Pol??nia, J., Boaventura, I., Gama, G., Cam??es, I., Bernardo, F., Andrade, P., Nunes, J. P., Brand??o, F., & Cerqueira-Gomes, M. (1995) · Journal of Hypertension · doi:10.1097/00004872-199508000-00014 · Cited by 63
Laiwah, A. C. Y., & MACTIER, R. A. (1981) · BMJ · doi:10.1136/bmj.283.6293.714 · Cited by 49
Brown, J. C., Dollery, C. T., & Valdés, G. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90907-1 · Cited by 43
Morgan, T. O., Anderson, A., Wilson, D., Myers, J. B., Murphy, J., & Nowson, C. A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91795-2 · Cited by 35
Self-citationFerri, C., Bellini, C., Piccoli, A., Carlomagno, A., Bonavita, M. S., Santucci, A., & BALSANO, F. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.875 · Cited by 33
The Effect of Perindopril on Blood Pressure in Humans on Different Sodium Intakes
Morgan, T. O., Anderson, A. I. E., Wilson, D., Murphy, J., & Nowson, C. A. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198706107-00023 · Cited by 24
Self-citationInteraction of indomethacin with felodipine and enalapril
Morgan, T., & Anderson, A. I. E. (1993) · Journal of Hypertension · doi:10.1097/00004872-199312050-00148 · Cited by 23
Self-citationCappuccio, F. P., Markandu, N. D., Tucker, F. A., Shore, A. C., & MacGregor, G. A. (1987) · Journal of Hypertension · doi:10.1097/00004872-198712000-00017 · Cited by 19
Research works printed but not linked: 2
- 1993, Journal of hypertension, 11, S338
- 1992, Kidney international, 41, S78
Cited by
Sorted by citations
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.ioi50013 · Cited by 329
Whelton, A., White, W. B., Bello, A. E., Puma, J. A., & Fort, J. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02661-9 · Cited by 310
Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue
Varga, Z., Sabzwari, S. R. A., & Vargova, V. (2017) · Cureus · doi:10.7759/cureus.1144 · Cited by 238
Effects of Celecoxib on Ambulatory Blood Pressure in Hypertensive Patients on ACE Inhibitors
White, W. B., Kent, J. D., Taylor, A. A., Verburg, K. M., Lefkowith, J. B., & Whelton, A. (2002) · Hypertension · doi:10.1161/01.hyp.0000014323.99765.16 · Cited by 149
Ruschitzka, F., Borer, J. S., Krum, H., Flammer, A. J., Yeomans, N. D., Libby, P., Lüscher, T. F., Solomon, D. H., Husni, M. E., Graham, D. Y., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx508 · Cited by 130
Cardiovascular Effects of the Cyclooxygenase Inhibitors
White, W. B. (2007) · Hypertension · doi:10.1161/01.hyp.0000258106.74139.25 · Cited by 128
COX-2 Selective Inhibitors in the Treatment of Osteoarthritis
Laine, L., White, W. B., Rostom, A., & Hochberg, M. C. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.10.004 · Cited by 125
Baker, W. L., Coleman, C. I., Kluger, J., Reinhart, K. M., Talati, R., Quercia, R., Phung, O. J., & White, C. M. (2009) · PubMed · doi:10.7326/0003-4819-151-12-200912150-00162 · Cited by 91
Aljadhey, H. S., Tu, W., Hansen, R. A., Blalock, S. J., Brater, D. C., & Murray, M. D. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-93 · Cited by 92
Common Secondary Causes of Resistant Hypertension and Rational for Treatment
Faselis, C. J., Doumas, M. N., & Papademetriou, V. (2011) · International Journal of Hypertension · doi:10.4061/2011/236239 · Cited by 89
The Effects of Nonsteroidal Anti-Inflammatory Drugs on Blood Pressure in Hypertensive Patients
Snowden, S., & Nelson, R. J. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e31821ddcf4 · Cited by 81
Izhar, M., Alausa, T., Folker, A., Hung, E., & Bakris, G. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000115921.55353.e0 · Cited by 77
Baker, W. L., Coleman, C. I., Kluger, J., Reinhart, K. M., Talati, R., Quercia, R., Phung, O. J., & White, C. M. (2009) · Annals of Internal Medicine · doi:10.7326/0000605-200912150-00162 · Cited by 99
Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.
Pavličević, I., Kuzmanić, M., Rumboldt, M., & Rumboldt, Z. (2008) · PubMed · Cited by 75
Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors
Komers, R., Anderson, S., & Epstein, M. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.29203 · Cited by 73
Drug-related hypertension and resistance to antihypertensive treatment
Rossi, G. P., Seccia, T. M., Maniero, C., & Pessina, A. C. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834c465d · Cited by 68
Antiplatelet agents and anticoagulants for hypertension
Lip, G. Y. H., Felmeden, D. C., & Dwivedi, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003186.pub3 · Cited by 65
Palmer, R. H. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03203-x · Cited by 56
Ishiguro, C., Fujita, T., Omori, T., Fujii, Y., Mayama, T., & Sato, T. S. (2008) · Journal of Epidemiology · doi:10.2188/jea.je2007413 · Cited by 55
Blue, N. R., Murray-Krezan, C. M., Drake-Lavelle, S., Weinberg, D., Holbrook, B. D., Katukuri, V. R., Leeman, L. M., & Mozurkewich, E. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.02.016 · Cited by 53
Magen, E., Viskoper, J. R., Mishal, J., Priluk, R., London, D., & Yosefy, C. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001910 · Cited by 50
Turtle, E. J., Dear, J. W., & Webb, D. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12032 · Cited by 48
White, W. B., Schnitzer, T. J., Fleming, R., Duquesroix, B., & Beekman, M. J. H. I. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.014 · Cited by 46
Defining the Problem of Treating the Patient with Hypertension and Arthritis Pain
White, W. B. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.03.002 · Cited by 46
Fogari, R., Zoppi, A., Carretta, R., Veglio, F., & Salvetti, A. (2002) · Journal of Hypertension · doi:10.1097/00004872-200205000-00037 · Cited by 43
The Effects of Pain and Analgesic Medications on Blood Pressure
Rivasi, G., Menale, S., Turrin, G., Coscarelli, A., Giordano, A., & Ungar, A. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01205-5 · Cited by 48
Viteri, O. A., England, J. A., Alrais, M. A., Lash, K. A., Villegas, M. I., Balogun, O. A., Chauhan, S. P., & Sibai, B. M. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002247 · Cited by 42
Acelajado, M. C., & Oparil, S. (2009) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.06.001 · Cited by 39
Cardiovascular risk, hypertension, and NSAIDs
White, W. B. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0020-3 · Cited by 40
Burnier, M. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.3.491 · Cited by 38
DeMaria, A. N., & Weir, M. R. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00630-9 · Cited by 37
COX-2-selective inhibitors in the treatment of arthritis.
Schnitzer, T. J., & Hochberg, M. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.suppl_1.si20 · Cited by 36
The case for cautious consumption
Sriperumbuduri, S., & Hiremath, S. S. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000473 · Cited by 36
Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity
Singh, B. K., Haque, S. E., & Pillai, K. K. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.856881 · Cited by 34
Nonsteroidal anti-inflammatory drugs in patients with cardioor cerebrovascular disorders
St�llberger, C., & Finsterer, J. (2003) · Zeitschrift für Kardiologie · doi:10.1007/s00392-003-0964-x · Cited by 34
Mackenzie, I. S., Rutherford, D., & MacDonald, T. M. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2464 · Cited by 34
Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses
Opie, L. H. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02215-4 · Cited by 32
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain
Angeli, F., Trapasso, M., Signorotti, S., Verdecchia, P., & Reboldi, G. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1540299 · Cited by 32
Antithrombotic therapy in hypertension: a Cochrane Systematic review
Felmeden, D. C., & Lip, G. Y. H. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001807 · Cited by 27
Antiplatelet agents and anticoagulants for hypertension
Shantsila, E., Kozieł-Siołkowska, M. M., & Lip, G. Y. H. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003186.pub4 · Cited by 27
Treatment of osteoarthritis in hypertensive patients
Mackenzie, I. S., & MacDonald, T. M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903496422 · Cited by 24
Treatment strategies for osteoarthritis patients with pain and hypertension
Verdecchia, P., Angeli, F., Mazzotta, G., Martire, P., Garofoli, M., Gentile, G., & Reboldi, G. (2010) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x10376120 · Cited by 25
MacDonald, T. M., Reginster, J., Littlejohn, T. W., Richard, D., Lheritier, K., Krammer, G., & Rebuli, R. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328302c9fe · Cited by 23
Gualtierotti, R., Zoppi, A., Mugellini, A., Derosa, G., D’Angelo, A., & Fogari, R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.816286 · Cited by 21
Nonsteroidal anti-inflammatory drugs and antihypertensives: how do they relate?
Khatchadourian, Z. D., Moreno‐Hay, I., & de Leeuw, R. (2014) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.02.028 · Cited by 21
Safety Considerations in Prescription of NSAIDs for Musculoskeletal Pain: A Narrative Review
Hatt, K., Vijapura, A., Maitin, I. B., & Cruz, E. S. (2018) · PM&R · doi:10.1016/j.pmrj.2018.06.011 · Cited by 21
Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis
Smith, S. M., & Cooper‐DeHoff, R. M. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.08.027 · Cited by 21
MacDonald, T. M., Richard, D., Lheritier, K., & Krammer, G. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02346.x · Cited by 19
Antiplatelet agents and anticoagulants for hypertension
Lip, G. Y. H., & Felmeden, D. C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003186.pub2 · Cited by 19
Zhukov, K. V., Vetcher, A. A., Gasparyan, B. A., & Shishonin, A. Y. (2021) · Polymers · doi:10.3390/polym13234248 · Cited by 18
Sica, D. A., & Prisant, L. M. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06504.x · Cited by 18
Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure
Aw, T., Haas, S. J., Liew, D., & Krum, H. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.05.026 · Cited by 18
The different patterns of blood pressure elevation by rofecoxib and nabumetone
Reitblat, T., Zamir, D., Estis, L., Priluk, R., Drogenikov, T., & Viskoper, J. R. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001411 · Cited by 18
Villa, J., Cano, A., Franco, D., Monsalve, M., Hincapié-García, J. A., & Amariles, P. (2014) · Atención Primaria · doi:10.1016/j.aprim.2013.11.010 · Cited by 17
Cardiovascular risk, hypertension, and NSAIDs
White, W. B. (2007) · Current Pain and Headache Reports · doi:10.1007/s11916-007-0229-x · Cited by 17
Hypertension Associated With Therapies to Treat Arthritis and Pain
White, W. B. (2004) · Hypertension · doi:10.1161/01.hyp.0000136129.18326.26 · Cited by 16
Effets rénaux et cardiovasculaires des anti-inflammatoires non stéroïdiens et des coxibs
Deray, G. (2004) · La Presse Médicale · doi:10.1016/s0755-4982(04)98637-x · Cited by 15
Aspirin: A Novel Antihypertensive Drug?
Messerli, F. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.050 · Cited by 15
Althobaiti, A. A., Ashour, E. A., Almotairy, A., Almutairi, M., Alyahya, M., & Repka, M. A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104117 · Cited by 14
Blood Pressure Destabilization on Nonsteroidal Antiinflammatory Agents
White, W. B., & Campbell, P. H. (2010) · Circulation · doi:10.1161/circulationaha.110.984054 · Cited by 13
Ruling out secondary causes of hypertension
Ott, C., Schneider, M. P., & Schmieder, R. E. (2013) · EuroIntervention · doi:10.4244/eijv9sra5 · Cited by 12
Interaction of Angiotensin-Converting Enzyme Inhibition and Aspirin in Congestive Heart Failure
Rocca, H. B. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1192 · Cited by 12
Blood Pressure Effects of Naproxcinod in Hypertensive Patients
Townsend, R. R., Bittar, N., Rosen, J., Smith, W., Ramsay, A., Chrysant, S. G., Weiss, R., Pivodic, A., Duquesroix, B., & Djian, J. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00419.x · Cited by 11
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
Papademetriou, V., Tsioufis, C. P., Gradman, A. H., & Punzi, H. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/438198 · Cited by 11
ASHP Therapeutic Position Statement on the Treatment of Hypertension
Zillich, A. J., & Haines, S. T. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060036 · Cited by 10
Non-steroidal anti-inflammatory drugs and antihypertensive drug therapy
Beilin, L. J. (2002) · Journal of Hypertension · doi:10.1097/00004872-200205000-00017 · Cited by 10
Spence, J. D. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02179-3 · Cited by 10
Epidemiologic characteristics of hypertension in the civilians of Kosovo after the war.
Markoglou, N. C., Hatzitolios, A. I., Savopoulos, C., Ziakas, A. G., Koutsopoulos, D., & Metallidis, S. (2005) · PubMed · Cited by 9
Nygård, P., Jansman, F. G. A., Kruik‐Kollöffel, W. J., Barnaart, A. F. W., & Brouwers, J. R. B. J. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9631-5 · Cited by 9
The Use of Calcium Antagonists in the Therapy of Hypertension in the Elderly
Israili, Z. H. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200311000-00003 · Cited by 8
NSAID use and BP in treated hypertensives: a retrospective controlled observational study
Sheridan, R., Montgomery, A. A., & Fahey, T. P. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001839 · Cited by 8
A Comparison of the Blood Pressure Changes of Lumiracoxib With Those of Ibuprofen and Naproxen
Farkouh, M. E., Verheugt, F. W. A., Ruland, S. D., Kirshner, H. S., Jeger, R. V., Gitton, X., Krammer, G., Stricker, K., Sallstig, P., Mellein, B., et al. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07802.x · Cited by 8
Prisant, L. M. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50156-3 · Cited by 7
Lattuca, B., Khoueiry, Z., Malclès, G., Davy, J., & Leclercq, F. (2013) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523011312010006 · Cited by 6
Factors Associated with Uncontrolled Hypertension in an Affluent, Elderly Population
Inciardi, J. F., McMahon, K., & Sauer, B. L. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c370 · Cited by 6
Samartsev, I. N., Живолупов, С. А., & Nazhmudinov, R. Z. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119121124 · Cited by 5
Cardiovascular Effects of the Selective Cyclooxygenase-2 Inhibitors
White, W. B. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_6 · Cited by 5
NLPZ a powikłania sercowo-naczyniowe i gastroenterologiczne — algorytm wyboru
Samborski, W., Sikorska, D., Niklas, A. A., Filipiak, K. J., Kaczmarczyk, J., Dobrowolska, A., & Tykarski, A. (2018) · Forum Reumatologiczne · doi:10.5603/fr.2018.0001 · Cited by 4
Specifics of the use of NSAIDs in senior age
Pakhomova, I. G., & Khoroshinina, L. P. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2016116111169-173 · Cited by 3
Health care cost of analgesic use in hypertensive patients
Mullins, C. D., Shaya, F. T., Flowers, L. R., Saunders, E., Johnson, W. R., & Wong, W. F. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90027-6 · Cited by 3
Goswami, S., Jain, S., Chudasama, H., & Santani, D. D. (2011) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2011.020 · Cited by 2
Genistein increases blood pressure in pre-treated normotensive rats
Awobajo, F. O., Ogbu, J. I., Adejare, A. A., Akpanika, G. A., Egede, C. B., & Timothy, B. O. (2023) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/166675 · Cited by 2
Treating Pain and Inflammation in Hypertension
White, W. B., Marfatia, R., & Baker, W. L. (2012) · Springer eBooks · doi:10.1007/978-88-470-2601-8_28 · Cited by 2
Impact of NSAIDs on cardiovascular risk and hypertension
White, W. B., & Cruz, C. (2011) · Italian Journal of Medicine · doi:10.1016/j.itjm.2011.04.007 · Cited by 2
Treating osteoarthrosis in terms of the safety of pharmacotherapy
Karateyev, A. E. (2009) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2009-524 · Cited by 2
Has the role of calcium channel blockers in treating hypertension finally been defined?
Chrysant, G. S., & Chrysant, S. G. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0037-6 · Cited by 2
Pendock, L. F. (2018) · doi:10.51415/10321/3157 · Cited by 2
Piszczatoski, C., & Smith, S. M. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1915289 · Cited by 1
Hypertensive Encephalopathy Triggered by Indomethacin Use
Plitman, J., Raco, V., & Wu, P. E. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9604 · Cited by 1
Management of Hypertension in Older Patients With Arthritis
Thavarajah, S., & White, W. B. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-911-0_23 · Cited by 1
Emerging therapies in the management of hypertensive patients with osteoarthritis
Gentile, G., Angeli, F., Mazzotta, G., Reboldi, G., & Verdecchia, P. (2011) · Clinical Investigation · doi:10.4155/cli.10.8 · Cited by 1
Calcium Channel Blockers: Controversies, Lessons, and Outcomes
Opie, L. H. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50128-9 · Cited by 1
Interacciones de drogas anti-hipertensivas
Acuña, F. P. (2008) · Revista Latinoamericana de Hipertensión/Revista Latinoamericana de Hipertensiòn
Papel de los inhibidores selectivos de la COX-2 en la hipertensión arterial
Suárez, C. R., Sien, C. C., de la Morena, J. S., & Urioste, L. M. R. (2004) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(04)71446-4
INCREASE IN TREATMENT-REFRACTORY HYPERTENSION: PROGRESS IN CURRENT TREATMENT BY PRIMARY CARE
Egan, B. M. (2011) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2011.09.004
Complications rénales des anti-inflammatoires non stéroïdiens
Izzedine, H., Launay‐Vacher, V., & Deray, G. (2004) · Revue du Rhumatisme · doi:10.1016/s1169-8330(04)80022-x
Manfaat AINS Terhadap Nyeri Gangguan Muskuloskeletal
Lelo, A., Rangkuty, Z., Pane, Y. S., & Kedokteran, F. (2004)
Ný og gömul gigtarlyf. Áhætta og ávinningur
Summary, E. (2003)
Pakhomova, I. G. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20161164185-89
Metadata
- Authors
- Morgan, T. O., Anderson, A., & Bertram, D.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Morgan, T. O.
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-11-01
- Volume
- 13
- Issue
- 11
- Pages
- 1161-1167
- ISSN
- 0895-7061 (ISSN-L)
- 1941-7225
- OpenAlex
- W2082572643
- Cited by
- 102
- References
- 18
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2019: 1 · 2018: 8 · 2017: 3 · 2016: 2 · 2014: 2 · 2013: 4 · 2012: 4
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- indomethacin, essential hypertension, elderly patients, amlodipine, enalapril, nonsteroidal anti-inflammatory drugs, sodium retention, blood pressure, plasma renin, prostaglandin synthesis, calcium channel blockers, ACE inhibitors, ambulatory blood pressure, pulse rate, weight gain
- MeSH terms
- Adult, Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Blood Pressure, Body Weight, Double-Blind Method, Drug Interactions, Dyspepsia, Enalapril, Female, Humans, Hypertension, Indomethacin, Male, Middle Aged, Nausea, Pain, Renin, Abdominal Pain, Amlodipine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review